Intraperitoneal Therapy for Ovarian Cancer
Springer Berlin (Verlag)
978-3-642-12129-6 (ISBN)
Prof. Alberts is Director of the Arizona Cancer Center in Tucson, AZ. He led a workshop on intraperitoneal chemotherapy in January 2006 at the Gynecologic Oncology Group meeting with 400 oncologists and nurses present. He also published the results of the first ever phase III trial comparing IV to IP chemotherapy in the New England Journal of Medicine.
Current Chemotherapy of Ovarian Cancer.- Principles of Intraperitoneal Chemotherapy.- Intraperitoneal Chemotherapy: Phase III Trials.- Criteria for Using Intraperitoneal (IP) Chemotherapy for Advanced Ovarian Cancer.- Selection and Placement of Intraperitoneal Catheters for IP Chemotherapy for Ovarian Cancer.- Selection of Drugs for Intraperitoneal Chemotherapy for Ovarian Cancer.- Administration Guidelines for Intraperitoneal Chemotherapy for Ovarian Cancer.- Novel Drugs for Intraperitoneal Therapy for Ovarian Cancer.- Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: An Ongoing Research Effort.- Health-Related Quality of Life and Patient-Reported Outcomes.
Erscheint lt. Verlag | 14.9.2010 |
---|---|
Zusatzinfo | VIII, 153 p. |
Verlagsort | Berlin |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 415 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Schlagworte | Appendiceal Cancer • Gastric cancer • intraperitoneal chemotherapy • Ovarialkrebs • Ovarialkrebs / Eierstockkrebs • ovarian cancer • Primary Peritoneal Cancer • Surgery |
ISBN-10 | 3-642-12129-2 / 3642121292 |
ISBN-13 | 978-3-642-12129-6 / 9783642121296 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich